Addus HomeCare (NASDAQ:ADUS) Shares Gap Down to $93.49

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $93.49, but opened at $89.23. Addus HomeCare shares last traded at $93.56, with a volume of 49,831 shares.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several analyst reports. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Oppenheimer reaffirmed an “outperform” rating and issued a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $103.00.

View Our Latest Analysis on ADUS

Addus HomeCare Stock Up 0.8 %

The stock has a market capitalization of $1.55 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 1.84 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The business’s fifty day moving average price is $97.66 and its two-hundred day moving average price is $91.56.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its earnings results on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. The company had revenue of $276.35 million during the quarter, compared to the consensus estimate of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. On average, equities research analysts forecast that Addus HomeCare Co. will post 4.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ADUS. TimesSquare Capital Management LLC lifted its position in Addus HomeCare by 55.0% during the third quarter. TimesSquare Capital Management LLC now owns 233,758 shares of the company’s stock valued at $19,914,000 after purchasing an additional 82,920 shares during the period. Allianz Asset Management GmbH acquired a new position in Addus HomeCare during the fourth quarter valued at $5,667,000. Vanguard Group Inc. lifted its position in Addus HomeCare by 4.9% during the third quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock valued at $103,809,000 after purchasing an additional 57,040 shares during the period. Jacobs Levy Equity Management Inc. lifted its position in Addus HomeCare by 127.7% during the third quarter. Jacobs Levy Equity Management Inc. now owns 100,158 shares of the company’s stock valued at $8,532,000 after purchasing an additional 56,171 shares during the period. Finally, Assenagon Asset Management S.A. raised its position in shares of Addus HomeCare by 78.8% in the first quarter. Assenagon Asset Management S.A. now owns 112,256 shares of the company’s stock worth $11,601,000 after acquiring an additional 49,483 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.